Optimal management of the morbidly obese patient SAGES appropriateness conference statement
- 27 May 2004
- journal article
- review article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 18 (7) , 1029-1037
- https://doi.org/10.1007/s00464-004-8132-6
Abstract
Obesity is a growing health problem that contributes to numerous life-threatening or disabling disorders, including coronary artery disease, hypertension, type 2 diabetes mellitus, hyperlipidemia, degenerative joint disease, and obstructive sleep apnea. Significant weight reduction in the morbidly obese improves or reverses associated illness and benefits well-being. The purpose of the SAGES Appropriateness Conference was to summarize the state of the art for open and laparoscopic operations for the morbidly obese. The English literature comparing bariatric procedures was reviewed and grouped by level of evidence by three surgeons (BS, LV, and CC). From more than 1,500 articles, all conference participants were provided with reprints and table summaries of no less than 50 selected manuscripts. Ten experts were requested to present reviews and make evidence-based arguments for and against the open and laparoscopic approaches in written format. An expert panel of six surgeons, including an ethicist and patient, commented on implications of data presented. The finalized statement was e-mailed to all participants for approval and comment. Consensus statements were achieved on various aspects of morbid obesity, including indications for surgery, resolution of comorbid illnesses with significant weight loss, and the importance of committed bariatric program. Our panel of experts agreed, in general, to the advantages of laparoscopic approaches compared to open operations in skilled hands. Laparoscopic Roux-en-Y gastric bypass (RYGB) affords improved short-term recovery compared to open gastric bypass. Laparoscopic adjustable banding can be performed with lower average mortality than either RYGB or any of the malabsorptive operations, and it produces variable degrees of short-term weight loss. Prospective randomized trials are needed to compare gastric bypass, malabsorptive, and restrictive procedures.Keywords
This publication has 40 references indexed in Scilit:
- Duodenal Switch: An Effective Therapy for Morbid Obesity - Intermediate ResultsObesity Surgery, 2001
- Laparoscopic Gastric Bypass, Roux en-Y - 500 Patients: Technique and Results, with 3-60 month follow-upObesity Surgery, 2000
- Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesityBritish Journal of Surgery, 1999
- Biliopancreatic DiversionWorld Journal of Surgery, 1998
- Prospective investigation of complications, reoperations, and sustained weight loss with an adjustable gastric banding device for treatment of morbid obesityJournal of Gastrointestinal Surgery, 1998
- Twenty-four-hour energy and nutrient balance in weight stable postobese patients after biliopancreatic diversionNutrition, 1996
- Surgery for Obesity - An Update of a Randomized TrialObesity Surgery, 1995
- Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference StatementThe American Journal of Clinical Nutrition, 1992
- A Randomized Prospective Trial of Gastric Bypass Versus Vertical Banded Gastroplasty for Morbid Obesity and their Effects on Sweets Versus Non-Sweets EatersAnnals of Surgery, 1987
- The Effectiveness of Gastric Bypass Over Gastric Partition in Morbid ObesityAnnals of Surgery, 1982